Mark A. Peterzan

754 total citations
20 papers, 519 citations indexed

About

Mark A. Peterzan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Mark A. Peterzan has authored 20 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Spectroscopy. Recurrent topics in Mark A. Peterzan's work include Advanced MRI Techniques and Applications (11 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac Imaging and Diagnostics (7 papers). Mark A. Peterzan is often cited by papers focused on Advanced MRI Techniques and Applications (11 papers), Cardiovascular Function and Risk Factors (9 papers) and Cardiac Imaging and Diagnostics (7 papers). Mark A. Peterzan collaborates with scholars based in United Kingdom, United States and Slovakia. Mark A. Peterzan's co-authors include Oliver J. Rider, Stefan Neubauer, Jennifer J. Rayner, Nish Chaturvedi, Rebecca Hardy, Alun D. Hughes, Andrew Lewis, Craig A. Lygate, Christopher T. Rodgers and William T. Clarke and has published in prestigious journals such as Circulation, Circulation Research and Hypertension.

In The Last Decade

Mark A. Peterzan

19 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Peterzan United Kingdom 11 348 183 95 79 66 20 519
Rasmus Stilling Tougaard Denmark 12 313 0.9× 170 0.9× 349 3.7× 155 2.0× 137 2.1× 22 700
Kenichi Mitsunami Japan 20 673 1.9× 613 3.3× 74 0.8× 44 0.6× 108 1.6× 55 1.2k
Angela Steinberg United States 10 256 0.7× 164 0.9× 18 0.2× 21 0.3× 96 1.5× 12 453
Jianmin Hua Australia 9 80 0.2× 180 1.0× 117 1.2× 31 0.4× 37 0.6× 21 403
Xudong Hu Canada 12 281 0.8× 89 0.5× 12 0.1× 81 1.0× 106 1.6× 20 519
Michaela Scheuermann‐Freestone United Kingdom 8 568 1.6× 193 1.1× 77 0.8× 31 0.4× 248 3.8× 11 840
R Schindler Germany 8 199 0.6× 189 1.0× 41 0.4× 24 0.3× 128 1.9× 24 443
Jennifer J. Rayner United Kingdom 15 396 1.1× 153 0.8× 57 0.6× 11 0.1× 51 0.8× 32 586
M. Kankaanpää Finland 4 246 0.7× 56 0.3× 79 0.8× 24 0.3× 56 0.8× 12 439
Wilfried Landschütz Germany 8 223 0.6× 235 1.3× 14 0.1× 28 0.4× 141 2.1× 13 445

Countries citing papers authored by Mark A. Peterzan

Since Specialization
Citations

This map shows the geographic impact of Mark A. Peterzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Peterzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Peterzan more than expected).

Fields of papers citing papers by Mark A. Peterzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Peterzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Peterzan. The network helps show where Mark A. Peterzan may publish in the future.

Co-authorship network of co-authors of Mark A. Peterzan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Peterzan. A scholar is included among the top collaborators of Mark A. Peterzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Peterzan. Mark A. Peterzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterzan, Mark A., et al.. (2023). Donor specific antibodies association with survival and adverse events after heart transplantation: A single center retrospective study between 2006 and 2021. Clinical Transplantation. 37(4). e14914–e14914. 4 indexed citations
2.
Henry, John A., Moritz Hundertmark, Mark A. Peterzan, et al.. (2022). Investigating myocardial energetic deficit across the spectrum of cardiac disease. European Heart Journal. 43(Supplement_2). 1 indexed citations
3.
Henry, John A., Eylem Levelt, Moritz Hundertmark, et al.. (2022). 143 Measuring pcr/atp as a marker of myocardial energetics across the spectrum of metabolic cardiac disease. A109.2–A110. 1 indexed citations
4.
Peterzan, Mark A., et al.. (2021). Water‐suppression cycling 3‐T cardiac 1H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis. NMR in Biomedicine. 34(7). e4513–e4513. 6 indexed citations
5.
Rayner, Jennifer J., Mark A. Peterzan, William T. Clarke, et al.. (2021). Obesity modifies the energetic phenotype of dilated cardiomyopathy. European Heart Journal. 28 indexed citations
6.
Hundertmark, Moritz, Matthew K. Burrage, Jack J. Miller, et al.. (2021). Abstract 11064: Intentional Weight Loss as a Novel Treatment for Heart Failure with Preserved Ejection Fraction. Circulation. 144(Suppl_1). 2 indexed citations
7.
Valkovič, Ladislav, Mark A. Peterzan, Justin Y. C. Lau, et al.. (2020). Quantifying the effect of dobutamine stress on myocardial Pi and pH in healthy volunteers: A 31P MRS study at 7T. Magnetic Resonance in Medicine. 85(3). 1147–1159. 12 indexed citations
8.
Peterzan, Mark A., Andrew Lewis, Stefan Neubauer, & Oliver J. Rider. (2020). Non-invasive investigation of myocardial energetics in cardiac disease using 31P magnetic resonance spectroscopy. Cardiovascular Diagnosis and Therapy. 10(3). 625–635. 8 indexed citations
9.
Rider, Oliver J., Jack J. Miller, Justin Y. C. Lau, et al.. (2020). Noninvasive In Vivo Assessment of Cardiac Metabolism in the Healthy and Diabetic Human Heart Using Hyperpolarized 13 C MRI. Circulation Research. 126(6). 725–736. 118 indexed citations
10.
Rayner, Jennifer J., Mark A. Peterzan, W. D. Watson, et al.. (2020). Myocardial Energetics in Obesity. Circulation. 141(14). 1152–1163. 61 indexed citations
11.
Peterzan, Mark A., William T. Clarke, Craig A. Lygate, et al.. (2020). Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction. Circulation. 141(24). 1971–1985. 13 indexed citations
12.
Clarke, William T., Mark A. Peterzan, Jennifer J. Rayner, et al.. (2019). Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T. NMR in Biomedicine. 32(6). e4085–e4085. 14 indexed citations
13.
Rayner, Jennifer J., Inès Abdesselam, Mark A. Peterzan, et al.. (2018). Very low calorie diets are associated with transient ventricular impairment before reversal of diastolic dysfunction in obesity. International Journal of Obesity. 43(12). 2536–2544. 14 indexed citations
14.
Lau, Justin Y. C., et al.. (2018). Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging. Heart. 104(18). 1484–1491. 23 indexed citations
15.
Abdesselam, Inès, et al.. (2018). 107Very low calorie diets lead to temporary and reversible left ventricular impairment. European Heart Journal. 39(suppl_1).
16.
Rayner, Jennifer J., Mark A. Peterzan, W. D. Watson, et al.. (2018). 5220Intentional weight loss substantially improves left ventricular systolic function in obese patients with heart failure with reduced ejection fraction. European Heart Journal. 39(suppl_1). 1 indexed citations
17.
Rayner, Jennifer J., Rajarshi Banerjee, Cameron Holloway, et al.. (2017). The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity. International Journal of Obesity. 42(3). 441–447. 56 indexed citations
18.
Rayner, Jennifer J., William T. Clarke, Mark A. Peterzan, et al.. (2017). P3331Obesity is associated with an increase in the forward rate constant of the creatine kinase reaction. European Heart Journal. 38(suppl_1). 1 indexed citations
19.
Peterzan, Mark A., Craig A. Lygate, Stefan Neubauer, & Oliver J. Rider. (2017). Metabolic remodeling in hypertrophied and failing myocardium: a review. American Journal of Physiology-Heart and Circulatory Physiology. 313(3). H597–H616. 67 indexed citations
20.
Peterzan, Mark A., Rebecca Hardy, Nish Chaturvedi, & Alun D. Hughes. (2012). Meta-Analysis of Dose-Response Relationships for Hydrochlorothiazide, Chlorthalidone, and Bendroflumethiazide on Blood Pressure, Serum Potassium, and Urate. Hypertension. 59(6). 1104–1109. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026